These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6662834)

  • 1. The in-vitro activity of bicozamycin against anaerobic bacteria of clinical interest.
    Watt B; Brown FV
    J Antimicrob Chemother; 1983 Dec; 12(6):549-53. PubMed ID: 6662834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activity against anaerobes of retapamulin, a new topical antibiotic for treatment of skin infections.
    Odou MF; Muller C; Calvet L; Dubreuil L
    J Antimicrob Chemother; 2007 Apr; 59(4):646-51. PubMed ID: 17350985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The growth-inhibitory properties of meropenem against anaerobes of clinical importance.
    Watt B; Naden M
    J Antimicrob Chemother; 1989 Sep; 24 Suppl A():119-24. PubMed ID: 2808203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activity of linezolid against anaerobic bacteria.
    Behra-Miellet J; Calvet L; Dubreuil L
    Int J Antimicrob Agents; 2003 Jul; 22(1):28-34. PubMed ID: 12842325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the in vitro activity of levornidazole, its metabolites and comparators against clinical anaerobic bacteria.
    Hu J; Zhang J; Wu S; Zhu D; Huang H; Chen Y; Yang Y; Zhang Y
    Int J Antimicrob Agents; 2014 Dec; 44(6):514-9. PubMed ID: 25301712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In-vitro comparison of roxithromycin and erythromycin against 900 anaerobic bacterial strains.
    Dubreuil L
    J Antimicrob Chemother; 1987 Nov; 20 Suppl B():13-9. PubMed ID: 3429381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ["In vitro" activity of ten antimicrobial agents against anaerobic bacteria. A collaborative study, 1999-2002].
    Litterio M; Bianchini H; Carloni G; Di Martino A; Fernández Canigia L; Greco G; Legaria C; Rollet R; Rossetti A; Predari SC; Castello L
    Rev Argent Microbiol; 2004; 36(3):130-5. PubMed ID: 15559195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activity of Bulgarian propolis against 94 clinical isolates of anaerobic bacteria.
    Boyanova L; Kolarov R; Gergova G; Mitov I
    Anaerobe; 2006 Aug; 12(4):173-7. PubMed ID: 16919977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro antimicrobial activity of razupenem (SMP-601, PTZ601) against anaerobic bacteria.
    Tran CM; Tanaka K; Yamagishi Y; Goto T; Mikamo H; Watanabe K
    Antimicrob Agents Chemother; 2011 May; 55(5):2398-402. PubMed ID: 21343447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-anaerobic activity of AZD2563, a new oxazolidinone, compared with eight other agents.
    Ednie LM; Jacobs MR; Appelbaum PC
    J Antimicrob Chemother; 2002 Jul; 50(1):101-5. PubMed ID: 12096013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Activity of doripenem against anaerobic bacteria].
    Dubreuil L; Neut C; Mahieux S; Muller-Serieys C; Jean-Pierre H; Marchandin H; Soussy CJ; Miara A
    Pathol Biol (Paris); 2011 Apr; 59(2):102-7. PubMed ID: 20537808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is ciprofloxacin active against clinically important anaerobes?
    Watt B; Brown FV
    J Antimicrob Chemother; 1986 May; 17(5):605-13. PubMed ID: 2941400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity against aerobes and anaerobes of trospectomycin versus spectinomycin.
    Gismondo MR; Chisari G; Lo Bue AM
    Drugs Exp Clin Res; 1991; 17(2):101-4. PubMed ID: 1830841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative inhibitory and bactericidal activities of FCE 22101 against gram-positive cocci and anaerobes in vitro.
    Maskell JP; Tang T; Asad S; Williams JD
    J Antimicrob Chemother; 1989 Mar; 23 Suppl C():65-74. PubMed ID: 2732145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Specificity of the anaerobic bacterial infections in the surgical and orthopedic wards].
    Kierzkowska M; Majewska A; Sawicka-Grzelak A; Młynarczyk A; Ładomirska-Pestkowska K; Młynarczyk G
    Med Dosw Mikrobiol; 2012; 64(1):29-34. PubMed ID: 22808727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antianaerobe activity of RBX 7644 (ranbezolid), a new oxazolidinone, compared with those of eight other agents.
    Ednie LM; Rattan A; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 2003 Mar; 47(3):1143-7. PubMed ID: 12604558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the in vitro activity of ertapenem and nine other comparator agents against 337 anaerobic bacteria.
    Behra-Miellet J; Dubreuil L; Calvet L
    Int J Antimicrob Agents; 2006 Jul; 28(1):25-35. PubMed ID: 16757152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro antibacterial activity of trospectomycin (U-63,366F) against anaerobic bacteria and aerobic gram-positive cocci in Chile.
    Montiel F; Kaltwasser G; Pinto ME; Lam M
    Diagn Microbiol Infect Dis; 1991; 14(3):259-64. PubMed ID: 1832369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative antibiotic susceptibilities of anaerobes associated with infections of the female reproductive tract.
    Madinger NE; McGregor JA; McKinney PJ; Dembeck ST; Haskell CS; Johnson Z
    Clin Infect Dis; 1993 Jun; 16 Suppl 4():S349-52. PubMed ID: 8324145
    [No Abstract]   [Full Text] [Related]  

  • 20. CEM-101, a novel fluoroketolide: antimicrobial activity against a diverse collection of Gram-positive and Gram-negative bacteria.
    Putnam SD; Castanheira M; Moet GJ; Farrell DJ; Jones RN
    Diagn Microbiol Infect Dis; 2010 Apr; 66(4):393-401. PubMed ID: 20022192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.